Avanos Medical Inc
NYSE:AVNS
Intrinsic Value
Avanos Medical, Inc. operates as a medical technology company. [ Read More ]
The intrinsic value of one AVNS stock under the Base Case scenario is 35.44 USD. Compared to the current market price of 19.91 USD, Avanos Medical Inc is Undervalued by 44%.
Valuation Backtest
Avanos Medical Inc
Run backtest to discover the historical profit from buying and selling AVNS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Avanos Medical Inc's business.
What risks and challenges
does Avanos Medical Inc face in the near future?
Summarize the latest earnings report
of Avanos Medical Inc.
Provide P/E
for Avanos Medical Inc and its competitors.
Balance Sheet Decomposition
Avanos Medical Inc
Current Assets | 487m |
Cash & Short-Term Investments | 87.7m |
Receivables | 142.8m |
Other Current Assets | 256.5m |
Non-Current Assets | 1.2B |
PP&E | 144m |
Intangibles | 1B |
Other Non-Current Assets | 25.8m |
Current Liabilities | 234.6m |
Accounts Payable | 56.3m |
Accrued Liabilities | 106m |
Other Current Liabilities | 72.3m |
Non-Current Liabilities | 221.5m |
Long-Term Debt | 159.4m |
Other Non-Current Liabilities | 62.1m |
Earnings Waterfall
Avanos Medical Inc
Revenue
|
673.3m
USD
|
Cost of Revenue
|
-293.6m
USD
|
Gross Profit
|
379.7m
USD
|
Operating Expenses
|
-375.5m
USD
|
Operating Income
|
4.2m
USD
|
Other Expenses
|
-66m
USD
|
Net Income
|
-61.8m
USD
|
Free Cash Flow Analysis
Avanos Medical Inc
What is Free Cash Flow?
AVNS Profitability Score
Profitability Due Diligence
Avanos Medical Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Avanos Medical Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
AVNS Solvency Score
Solvency Due Diligence
Avanos Medical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Avanos Medical Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AVNS Price Targets Summary
Avanos Medical Inc
According to Wall Street analysts, the average 1-year price target for AVNS is 23.97 USD with a low forecast of 20.2 USD and a high forecast of 28.35 USD.
Ownership
AVNS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
AVNS Price
Avanos Medical Inc
Average Annual Return | -8.2% |
Standard Deviation of Annual Returns | 26.93% |
Max Drawdown | -67% |
Market Capitalization | 919.3m USD |
Shares Outstanding | 46 203 000 |
Percentage of Shares Shorted | 3.87% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Avanos Medical, Inc. operates as a medical technology company. The company is headquartered in Alpharetta, Georgia and currently employs 4,555 full-time employees. The company went IPO on 2014-10-21. The firm develops, manufactures and markets solutions in approximately 90 countries. The company provides a portfolio of product offerings focused on chronic care and pain management to improve patient outcomes. Chronic care is a portfolio of products, which include digestive health products, such as its Mic-Key enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as its closed airway suction systems and other airway management devices under the Ballard, Microcuff and Endoclear brands. Pain management is a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and Interventional pain solutions, which provides pain relieving therapies, such as its Coolief pain therapy.
Contact
IPO
Employees
Officers
The intrinsic value of one AVNS stock under the Base Case scenario is 35.44 USD.
Compared to the current market price of 19.91 USD, Avanos Medical Inc is Undervalued by 44%.